Eli Lilly warns EU will miss out on key drugs under planned change to patent rules | Curio
News and insights read out for you.
10,000+ audio articles. 50+ world-leading publications.

All in 1 subscription.

Start your 7-day free trialLearn more
Financial Times logo

Eli Lilly warns EU will miss out on key drugs under planned change to patent rules

5 mins | May 9, 2023
story image

Could new laws mean that Europe misses out on critical pharmaceuticals? The Financial Times discusses leading pharma group Eli Lilly CEO's concerns over legislation overhaul.

Get unlimited access free for 7 days, then $8.33/month (billed annually)
Get started